Proof of Usefulness Report

The Connecting Architects

Analysis completed on 2/14/2026

+36
Proof of Usefulness Score
You're In Business

The Connecting Architects is a verifiable boutique advisory firm specializing in life sciences and biotech, founded by experienced entrepreneurs (Victoria Betoeski, John Tchelingerian). Search results confirm their role in the TikoMed/IQVIA strategic collaboration (2022). However, this submission evaluates a service-based consulting business as a technology project, resulting in low innovation scores. The submission quality is notably poor, containing hyperbolic and false claims (e.g., 'most people have used my product', audience is 'everyone', and 'marketcap' used in place of revenue). While the business is legitimate and functional, it lacks the scalable technology and broad user base required for a high PoU score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+18.75
Audience Reach Impact+2.00
Technical Innovation+0.38
Evidence Of Traction+6.88
Market Timing Relevance+7.00
Functional Completeness+0.50
Subtotal+35.51
Usefulness Multiplierx1.02
Final Score+36

Project Details

Project URL
theconnectingarchitects.com
Description
The Connecting Architects provides strategic, business development and external growth advisory services to investors and innovative companies to support their growth and global scale up. Full service platform with global partners in US, EU and Asia for both entrepreneurial and advisory services to support deal-making for early and mid-stage companies and venture building. Broad expertise in life sciences, biotech, health tech, digital health and food tech. A few case studies: • Advised a Swedish biopharma, TikoMed AB, on a strategic collaboration with IQVIA. • Advised on first international institutional capital raise for a Health Tech company in the ophthalmology space. • Advising an Italian early-stage biotech developing a neuroprotective treatment for glaucoma • Advising a Dutch biotech on International Series A and business development and licensing. • Advised an EU biotech on bridge financing from existing and new (Asian) investors.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline